VivoSeq
Other

Postmenopausal Women

0

Pipeline Programs↗

18

Active Trials↗

33

Companies Involved↗

Postmenopausal Women is an early-stage landscape with 0 programs across 33 companies. The most active players are Faculty of Medicine of Tunis, Pfizer, Merck & Co..

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

25/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

10/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

F

Faculty of Medicine of Tunis

2 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalAmgen logo

Amgen

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalBayer logo

Bayer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

210

clinical trials

Completed156 · 74%
Terminated18 · 9%
Unknown status14 · 7%
Recruiting9 · 4%
Not yet recruiting6 · 3%
Withdrawn4 · 2%
Other3 · 1%

Clinical Trials

Trial Activity

210 trials

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
Recruiting·—·Phase 2/3·NCT06220266·10 enrolled
Estrogen Administration for the Treatment of NASH in Postmenopausal Women
Recruiting·MMassachusetts General Hospital·Phase 3·NCT04833140·60 enrolled
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women
Recruiting·IImmuneOnco Biopharmaceuticals (Shanghai) Inc.·Phase 1·NCT07118085·56 enrolled
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes
Recruiting·—·N/A·NCT06715514·96 enrolled
Study of HS-10384 in Participants of Chinese Postmenopausal Women
Recruiting·HHansoh BioMedical R&D Company·Phase 1·NCT06122181·48 enrolled
Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women
Recruiting·OOdense University Hospital·Phase 2·NCT06789900·136 enrolled
Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
Recruiting·UUniversity of Aarhus·Phase 4·NCT07160504·90 enrolled
Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women
Recruiting·—·N/A·NCT06600347·90 enrolled
A Four-Arm Prospective Randomized Controlled Trial Comparing Oral Misoprostol, Two Vaginal Estrogen Regimens, and No Cervical Preparation Before Office Hysteroscopy in Postmenopausal Women
Recruiting·FFaculty of Medicine of Tunis·Preclinical·NCT07697781·120 enrolled
Hormonal Mechanisms of Sleep Restriction - Axis Study in Older Men and Postmenopausal Women
Active, not recruiting·LLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center·Phase 1·NCT04037605·5 enrolled
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
Active, not recruiting·AAngitia Biopharmaceuticals·Phase 2·NCT06577935·379 enrolled
Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)
Active, not recruiting·—·Phase 2·NCT04895306·40 enrolled
Pain Management During Diagnostic Office Hysteroscopy in Postmenopausal Women: a Randomized Study
Not yet recruiting·—·Phase 4·NCT06767085·106 enrolled
Effect of Esketamine on Postoperative Sleep in Postmenopausal Women
Not yet recruiting·—·N/A·NCT07315074·164 enrolled
A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women
Not yet recruiting·HHansoh BioMedical R&D Company·Phase 2·NCT06393673·195 enrolled
Page 1 of 14

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)